Matches tumor biomarkers to treatments and predicts how a patient's cancer is likely to respond.
Consented intake · your records travel with you · nothing moves without your sign-off
Pangea Biomed works on biomarker-drug matching and treatment response prediction. From a patient's disease profile, it helps recommend the treatment options with the most likely effective response and assess confidence in the expected outcome. It is for patients who want their options ranked by predicted response, drawing on the best global thinking about their type of cancer.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how Pangea Biomed handles billing.
We don't have confirmed insurance details for Pangea Biomed yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in Pangea's details here. Educational only; your oncologist directs treatment.
Powered by Navis on opencancer.ai
Other providers in similar categories.
Identify the best treatment ideas using the best global thinking, predict best treatment response
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.